Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

An Alzheimer’s Drug’s Big Surprise: What It Means

Por: MarketWatch Business October 01, 2022

thumbnail

For Biogen, a failure would have revived talk of breaking up the biotech, while positive results may lead to a megablockbuster drug—and make it easier to hire a new CEO to replace exiting Michel Vounatsos. Mizuho analyst Salim Syed wrote that he is modeling $8 billion in peak annual worldwide lecanemab sales. Lecanemab profits will be split 50/50 between Biogen and Eisai. The data also stir hope that drugs from and in trials will also show... + full article



Similar News

Alzheimer's drug slows progression of cognitive decline in clinical trial, drugmakers say

CNN USA Health September 28, 2022

thumbnailCNN  —  A monoclonal antibody treatment for Alzheimer’s disease called lecanemab slows the progression of cognitive decline by 27% compared with a placebo, drugmakers Biogen and Eisai said Tuesday. The drug, tested in a Phase 3 global clinical trial, also met all secondary... + más

New test can detect plaques early in the disease: Alzheimer's Q&A | The Advocate

Experimental Alzheimer’s drug slows cognitive decline in trial, firms say | Portland Press Herald


Alzheimer's drug shows promise in early results of study

WPLG Local 10 USA Health September 28, 2022

thumbnailShares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study. The drugmaker said early results showed that its treatment, lecanemab,... + más

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald

How To Spot The Early Signs Of Alzheimer's | Newsweek


Alzheimer's drug shows promise in early results of study

Associated Press USA Health September 28, 2022

thumbnailShares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study. The drugmaker said early results showed that its treatment, lecanemab,... + más

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald

How To Spot The Early Signs Of Alzheimer's | Newsweek


How To Spot The Early Signs Of Alzheimer's

Newsweek USA Health September 24, 2022

thumbnailThe Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más

COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate


COVID-19 in seniors linked to increased Alzheimer’s risk, study finds

Portland Press Herald USA Health September 24, 2022

thumbnailA study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate

How To Spot The Early Signs Of Alzheimer's | Newsweek


There's a growing dementia crisis in the veteran community: Alzheimer's Q&A

The Advocate USA Health September 17, 2022

thumbnailAre U.S. veterans more at risk for Alzheimer’s or other dementias?The U.S. is in the midst of a dramatic rise in the number of veterans with Alzheimer’s disease and other dementias, and many of these new cases are directly attributable to military service.According to a 2017... + más

Stroke can lead to vascular dementia: Alzheimer's Q&A | The Advocate

Alzheimer's Q&A: Let go of negative thoughts | The Advocate


Alzheimer's Q&A: Sildenafil has potential as Alzheimer's drug

The Advocate USA Health September 17, 2022

thumbnailIs sildenafil being considered as a potential treatment for Alzheimer’s disease?Sildenafil could potentially be used as a treatment for Alzheimer’s disease, according to findings recently published in Nature Aging by Feixong Cheng, of the Cleveland Clinic.Per MedlinePlus, an... + más

There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate

US warns monkeypox could mutate to resist antiviral drug | ABC News



About iurex | Privacy Policy | Disclaimer |